Table 3.
miRNA Expression Change in AD Lesions or Serum |
Associated Effect |
---|---|
↓Let-7 a-d | ↑IL-13↑CCR7 |
↓miR-375 | ↑TSLP (Thymic stromal lymphopoietin) |
↓hsa-miR-26a-5a | ↑HAS3 (hyaluronian 3 synthase) |
↑miR-21 | ↓IL12 |
↑miR-29b | Promotion of INF-γ-induced keratinocyte apoptosis |
↑miR-146a | ↓STAT1 and decrease in Treg activation ↓NFκB–pro-inflammatory transcription factor |
↑miR-155 | ↓CTLA-4 and decrease in Treg proliferation ↑Promotion of Th17 differentiation ↓Inhibition of tight junction formation |
↑miR-223 in umbilical cord blood | Decrease in Treg activation |
↑MiR-151a in serum | Inhibition of IL-12 signaling |
Other miRNA expression changes in atopic skin: ↑ miR-17-5p, ↑ miR142-3p/5p, ↓ miR-122a, ↓miR-326, ↓miR-133b, ↓miR-125b, ↓miR375, ↓ miR193c, ↓miR365 |